AI Article Synopsis
- - This study investigated how well the probiotic strain PMO08 survives and adapts in the human gut, finding that while 92.70% was damaged in the gastric and small intestinal environments, a small percentage still persisted.
- - When tested in the colon, PMO08 not only increased in abundance but also promoted the growth of beneficial bacteria, enhancing microbial diversity.
- - Additionally, PMO08 significantly boosted the production of beneficial compounds like short-chain fatty acids and organic acids, showing its potential as a probiotic in the colon despite moderate viability in harsher gastrointestinal conditions.
Article Abstract
This study aimed to evaluate the survivability of PMO08 in the human gastrointestinal tract and its adaptability in the colon using in vitro models. After exposure to gastric and small intestinal conditions, the majority (92.70 ± 1.14%) of PMO08 was found to be damaged, as determined by confocal microscopy and flow cytometry. During in vitro colonic fermentation, PMO08 not only increased abundance up to 0.47 ± 0.04% compared with the control sample (0.00 ± 0.00%) at 24 h but also facilitated the growth of beneficial or commensal bacteria, thereby increasing the α-diversity indices. Additionally, PMO08 significantly elevated the levels of short-chain fatty acids (SCFAs) and various organic acids. Our results demonstrate that PMO08 possesses moderate viability under gastrointestinal conditions but exhibits superior probiotic activity in the colon.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11315860 | PMC |
| http://dx.doi.org/10.1007/s10068-024-01622-z | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!